The Drag — Can Edelweiss Stop Its Insurers Bleeding by FY27?

The Drag — Can Edelweiss Stop Its Insurers Bleeding by FY27?

Every chapter so far has valued an engine. Chapter 3 valued asset reconstruction at book; Chapter 4 valued the alternatives platform as an option on a full-price IPO. This chapter values the part of Edelweiss that runs the other way — the two insurance businesses that have lost money every year for as long as the group has reported segment profit, and that the whole sum-of-the-parts must absorb until they stop. The bottom line: the insurance drag cost the consolidated number ₹216 crore in FY2026, and — after three straight years of shrinking — that loss widened in FY2026 [1]. Management blames a one-time tax hit and insists both businesses break even in FY2027 [2]. That promise — repeated since 2024 — is the single swing factor that decides whether this part of the group is a closing wound or a recurring leak.

Two businesses, both owned by you

Edelweiss runs life insurance through Edelweiss Life Insurance (ELI), 80% owned by the holding company, and general insurance through Zuno General Insurance, 100% owned [3]. Unlike asset reconstruction — where a 40% minority siphons off a third of the headline profit — almost all of the insurance loss lands on Edelweiss shareholders. That ownership is the reason the drag matters to the equity: there is no large outside partner sharing it.

Neither business is small or failing on the top line. Life wrote ₹2,221 crore of gross premium in FY2026 and carries ₹10,425 crore of AUM; Zuno's gross written premium grew 28% to ₹1,294 crore, with motor premium up 27% against industry growth of 9% [4] [5]. The problem has never been growth. It has always been that growth in insurance is bought with up-front cost, and these two have not yet reached the scale where the premium covers it.

The loss that was supposed to be ending — and grew

Here is the trajectory the bull case relies on, and the year it broke.

Sources: FY2026 Q4 presentation, consolidated PAT by business [6]; FY2024 Q4 presentation, Life and General Insurance snapshots [7] [8].

For three years the line did exactly what management promised. Combined insurance losses fell from ₹324 crore in FY2023 to ₹280 crore (FY2024) to ₹175 crore (FY2025). Then in FY2026 they widened to ₹216 crore — Life from a ₹127 crore loss to ₹159 crore, Zuno from ₹48 crore to ₹57 crore [9]. Across FY2023–FY2026 the two businesses booked roughly ₹1,000 crore of cumulative reported losses, the great majority borne by Edelweiss holders.

Source: FY2026 Q4 presentation, PAT by business and Life snapshot [10] [11]; cumulative figure derived from reported segment PAT FY2023–FY2026.

A promise on its fourth year

The reason the FY2026 reversal stings is that "breakeven by FY27" is not a new claim — it is a commitment the company has been making, in almost identical words, for years. The corpus lets you watch it travel:

When	What management said	Source
Q4 FY2024 (May 2024)	"The losses on insurance businesses have peaked. They have started falling… insurance to be breakeven by [FY]27. We remain on track."	[12]
Q4 FY2025 (May 2025)	"We will get the insurance businesses to break even in the next 18 to 24 months." General insurance "5 to 6 quarters away."	[13]
Q1 FY2026 (Aug 2025)	"On track to breakeven by FY '27… this year [FY26] to be a loss collectively."	[14]
Q2 FY2026 (Nov 2025)	"On track to breakeven by FY27… both the businesses are on track."	[15]
Q4 FY2026 (Apr 2026)	"The loss has gone up… we still remain committed that we will be breakeven for the year FY '27."	[16]

Source: Edelweiss earnings-call transcripts, FY2024–FY2026.

The destination has stayed fixed at FY2027 while the path beneath it moved. In May 2024 the losses had "peaked" and were "falling." By April 2026 they were rising again, and FY2027 breakeven now requires the combined loss to swing from minus ₹216 crore to zero in a single twelve-month stretch — a sharper inflection than any year in the record above produced.

The defense — and where it holds

Management has a specific answer, and a skeptic has to weigh it honestly. Of the ₹159 crore Life loss in FY2026, roughly ₹70 crore was a one-time goods-and-services-tax hit, and total exceptional items across both insurers — GST plus a new labour-code charge — came to about ₹110 crore. Strip those out, the company argues, and the combined loss was nearer ₹100 crore versus ₹170 crore the year before — i.e. the underlying trend kept improving [17]. That is plausible: a GST reclassification on life premium is genuinely non-recurring.

The deeper point is more important, and it is the reason a life-insurance loss is not the same as a general loss. Life-insurance IGAAP losses are largely a growth choice, not value destruction. New business is written at an up-front cost; the profit emerges over the policy's life. Rashesh Shah is blunt about it: "if you grow at 0%, you will break even in a quarter, because all loss is for acquiring customers." The company's stated plan is to grow Life at 13–15% and general insurance at 18–20% a year and still reach breakeven, rather than buy profitability by stopping growth [18].

The proof that the life book is building value while reporting losses is its embedded value — the actuarial present value of the in-force book — which has climbed every year even as the P&L stayed red:

Sources: FY2024 Q4 presentation (₹1,951 cr, Mar-2024) [19]; FY2025 Q4 presentation (₹2,186 cr, +12%) [20]; FY2026 Q4 presentation (₹2,363 cr, +8%) [21].

Embedded value rose from ₹1,951 crore (Mar-2024) to ₹2,363 crore (Mar-2026), up 21% over two years through the same period the business reported cumulative IGAAP losses [22] [23]. That ₹2,363 crore is roughly 2.5 times the entity's ₹934 crore IGAAP net worth [24] — which is exactly why Chapter 2 marked Life at embedded value rather than book. Management's further claim that under incoming Ind AS / IFRS-17 accounting the business would "be breakeven even now" is self-serving but directionally true: those standards spread acquisition cost rather than front-loading it [25].

Zuno is the harder case

General insurance does not get the life-insurance defense. A motor-insurance loss is an underwriting-and-overhead loss, not deferred profit waiting in an embedded value. The honest metric is the combined ratio — claims plus expenses as a share of premium — and Zuno's is still well above 100%. Management put it at 122–123%, down from 135% a few years ago, with breakeven around 107–108% and a "good" Indian insurer near 105% [26]. That is real progress, but it is roughly fifteen points of ratio still to close, and Zuno's loss actually widened in FY2026 (₹48 crore to ₹57 crore) rather than narrowing [27]. In May 2025 management said general insurance was "5 to 6 quarters away" from breakeven [28]; a year later the loss was bigger. Of the two, Zuno is the one whose FY2027 breakeven rests on operating leverage that has not yet shown up.

What it means for the case

For the through-line, this chapter quantifies the clause the thesis names explicitly — the insurance businesses still lose money — and dates its possible end.

Two things keep this from being a simple bear point. First, the life book is genuinely creating value — embedded value up 21% in two years, now 2.5x net worth — so Chapter 2's decision to carry Life above book is earned, not generous. Second, the headline ₹110 crore of FY2026 exceptional items is real and non-recurring, so the underlying loss did keep shrinking. But the burden of proof has shifted onto management. A breakeven promise in its fourth year, made the same year the loss it was meant to be ending grew, is a promise that FY2027's numbers — not the next call's language — now have to keep. Until they do, the prudent reader treats insurance as a roughly ₹200 crore annual headwind that the rest of the group's earnings, and the value-unlock cash earmarked for FY2027 [29], still have to carry.